NLRP3 and posterior cortical atrophy: By counteracting the upregulation of the NLRP3 inflammasome in PCa cells with the Caspase-1 inhibitor Z-YVAD-FMK, authors have been able to impair PCa growth through in vitro and in vivo experimental approaches [202] (Fig. 5).